NY A00705 | 2021-2022 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 6 2021 - 25% progression, died in committee
Action: 2022-04-27 - print number 705b
Pending: Assembly Ways and Means Committee
Text: Latest bill text (Amended) [HTML]

Summary

Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

Sponsors


Roll Calls


History

DateChamberAction
2022-04-27Assemblyprint number 705b
2022-04-27Assemblyamend and recommit to ways and means
2022-01-05Assemblyreferred to ways and means
2021-05-24Assemblyreported referred to ways and means
2021-05-13Assemblyprint number 705a
2021-05-13Assemblyamend and recommit to alcoholism and drug abuse
2021-01-06Assemblyreferred to alcoholism and drug abuse

Same As/Similar To

S06746 (Same As) 2022-05-25 - referred to ways and means

New York State Sources


Bill Comments

feedback